Clinico-Mycological Pattern of Hair and Skin Infection in New Delhi

Kaur, Ravinder

doi:10.21767/2471-8505.100074

Cited by 7 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast, dermatophytosis infection, known as ringworm or tinea, includes skin lesions such as tinea capitis, tinea cruris, tinea pedis, tinea barbae, tinea manuum, tinea faciei, and tinea corporis. 10 Likewise, yeasts are responsible for candidiasis, thrush, and rashes occurring on different parts of the host body. 6,9 The causal organism colonizes only the cornified epidermal layer or supra-follicular portions of hair but does not penetrate the deeper skin layers.…”

Section: Disease Pathogen and Treatmentmentioning

confidence: 99%

“…The dermatophytes include Trichophyton sp., Microsporum sp., and Epidermophyton sp., whereas the yeast group comprises Malassezia sp., Candida sp., Acremonium sp., Cladosporium sp, Scytalidium sp, Scopulariopsis sp, among others. In contrast, dermatophytosis infection, known as ringworm or tinea, includes skin lesions such as tinea capitis, tinea cruris, tinea pedis, tinea barbae, tinea manuum, tinea faciei, and tinea corporis 10 . Likewise, yeasts are responsible for candidiasis, thrush, and rashes occurring on different parts of the host body 6,9 .…”

Section: Disease Pathogen and Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Natural products of plant origin: an emerging therapeutic for dermatomycosis

Biswas,

Mukherjee,

Ghosh

et al. 2024

Int J Dermatology

View full text Add to dashboard Cite

Dermatomycosis or superficial mycosis is considered one of the chronic fungal infections and a global challenge for the public health system. The severity of dermatomycosis is proportionately increasing with the emerging population of immunocompromised individuals, and it is becoming more prevalent, even life‐threatening, in several tropical countries. In this context, improper long‐term treatment with synthetic antifungal drugs and their related side effects imposes additional challenges in treating dermatomycosis. Thus, the present scenario highlights the need for a novel and accurate treatment with minimal or no side effects. The multifaceted therapeutic properties of various natural products have garnered the interest of scientific communities in recent years. Generally, plant‐based products have low toxicity levels and offer diverse formulations and unique biomolecules for clinical applicability against dermatomycosis. Thus, this study presents an overview of the pathogenesis and different treatment strategies for dermatomycosis. In addition, we highlight the implementation of natural products of plant origin for treating dermatomycosis infections and reducing adverse events. Further, their mode of action and role in the development of pharmaceutical drugs are discussed.

show abstract

Section: Disease Pathogen and Treatmentmentioning

confidence: 99%

Section: Disease Pathogen and Treatmentmentioning

confidence: 99%

Natural products of plant origin: an emerging therapeutic for dermatomycosis

Biswas,

Mukherjee,

Ghosh

et al. 2024

Int J Dermatology

View full text Add to dashboard Cite

show abstract

“…Unfortunately, the poor patients cannot afford this costly treatment, so they purchase inexpensive FDCs sold over the counter, which do not help the patients and only prolong their suffering. This can lead to a chronic, resistant form of dermatophytosis and may promote fungal resistance [22][23][24][25]. There are insufficient accredited laboratories in the country, and only a handful of laboratories conduct antifungal susceptibility testing.…”

Section: Agementioning

confidence: 99%

Trichophyton Interdigitale Causing Severe Tinea Corporis and Tinea Cruris Et Corporis

Hussain¹

View full text Add to dashboard Cite

Background :Since many years, India has been plagued by an epidemic-like scenario of chronic, extensive, and resistant dermatophytosis. Dermatophytosis, also known as tinea, was once regarded as a minor infection that was simple to treat. Without oral antifungal agents, the use of such topical preparations to treat dermatophytosis can result in extensive lesions and fungal resistance. This study aimed to determine the aetiology and dermatophyte species associated with tinea corporis and tinea cruris et corporis with extensive lesions. Methods :The Department of Dermatology at the tertiary care centre conducted a study for two years. The consent of 158 patients was obtained. All patients with clinical findings of tinea corporis and tinea cruris et corporis who tested positive for KOH and/or culture were enrolled in the study. A thorough history was obtained. Findings:Results indicated that 149 (94.30%) were KOH positive and 158 (100%) were culture positive. Only Trichophyton interdigitale was isolated from 158 patients. None of the patients tested positive for HIV, and six patients (4%) had diabetes. Seventy percent of the patients reported using antifungal, antibiotic, and topical steroid creams in various combinations, and nearly ten percent used corticosteroid creams alone. Rest was unaware of the name of the moisturiser they used. Conclusion :Local immunity is lowered by topical steroids, which contribute to the development of extensive and atypical lesions. Dermatomycosis has reached epidemic proportions in this Katihar region. This region is rife with the misuse of unregulated steroid mixtures.

show abstract

Talaromyces stipitatus, a novel agent causing superficial mycosis in a diabetic patient from North India

Sharma

Nonzom

2022

Microbes and Infection

View full text Add to dashboard Cite

Clinico-Mycological Pattern of Hair and Skin Infection in New Delhi

Cited by 7 publications

References 6 publications

Natural products of plant origin: an emerging therapeutic for dermatomycosis

Natural products of plant origin: an emerging therapeutic for dermatomycosis

Trichophyton Interdigitale Causing Severe Tinea Corporis and Tinea Cruris Et Corporis

Talaromyces stipitatus, a novel agent causing superficial mycosis in a diabetic patient from North India

Contact Info

Product

Resources

About